Barclays PLC Reduces Position in Arcus Biosciences, Inc. (NYSE:RCUS)
Barclays PLC reduced its stake in Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) by 4.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 113,038 shares of the company’s stock after selling 5,655 shares during the quarter. Barclays PLC owned about 0.12% […]
